Shares of drugmaker Cipla are expected to be in focus on Monday ... These do not represent the views of Economic Times) ...

Unlike some of its peers, which will see sharp decline in FY27E profitability vs FY26E given higher gRevlimid contribution, we see negligible decline in case of Cipla. Further, Cipla’s strong ...

A total of 1.39 crore shares of Cipla Ltd, representing 1.72 percent of the company’s equity, were sold through block deals on Monday. Promoters are the likely sellers, as reported previously by ...